SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-16-007840
Filing Date
2016-02-11
Accepted
2016-02-11 14:01:15
Documents
16
Period of Report
2016-02-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_021116.htm 8-K 12907
2 EXHIBIT 99.1 exh_991.htm EX-99.1 7774
3 GRAPHIC exh991_01.jpg GRAPHIC 89211
4 GRAPHIC exh991_02.jpg GRAPHIC 142172
5 GRAPHIC exh991_03.jpg GRAPHIC 152244
6 GRAPHIC exh991_04.jpg GRAPHIC 184605
7 GRAPHIC exh991_05.jpg GRAPHIC 162818
8 GRAPHIC exh991_06.jpg GRAPHIC 149904
9 GRAPHIC exh991_07.jpg GRAPHIC 170430
10 GRAPHIC exh991_08.jpg GRAPHIC 170276
11 GRAPHIC exh991_09.jpg GRAPHIC 146310
12 GRAPHIC exh991_10.jpg GRAPHIC 155672
13 GRAPHIC exh991_11.jpg GRAPHIC 128904
14 GRAPHIC exh991_12.jpg GRAPHIC 148829
15 GRAPHIC exh991_13.jpg GRAPHIC 142513
16 GRAPHIC exh991_14.jpg GRAPHIC 129393
  Complete submission text file 0001171843-16-007840.txt   2871018
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21214 | Film No.: 161410624
SIC: 2834 Pharmaceutical Preparations